• Cisapride (R 51619): Benchmarks for Cardiac Electrophysiolog

  2026-06-06

  Cisapride (R 51619) is a well-characterized nonselective 5-HT4 receptor agonist and potent hERG potassium channel inhibitor, widely used in cardiac electrophysiology research. Its reproducible performance in iPSC-derived cardiomyocyte models and deep learning-enabled toxicity screens sets a high standard for predictive cardiotoxicity assessment.

• Docosahexaenoic Acid (DHA): Mechanisms and Emerging Immunomo

  2026-06-05

  Explore how Docosahexaenoic Acid (DHA) advances neuroprotection and anti-inflammatory research. This in-depth article uncovers unique mechanistic roles and highlights the evolving link between omega-3 fatty acids and immune modulation.

• MAPK10 Phosphorylation Drives KRT16 Degradation in NSCLC Met

  2026-06-05

  The referenced study demonstrates that MAPK10 suppresses non-small cell lung cancer (NSCLC) metastasis by phosphorylating keratin 16 (KRT16), which promotes its ubiquitination and proteasomal degradation. This mechanistic insight establishes the MAPK10/KRT16/RNF213 axis as a novel prognostic and therapeutic target for NSCLC.

• Capsaicin in Bench Research: Protocols & Advanced Applicatio

  2026-06-04

  Capsaicin ((E)-Capsaicin) is redefining experimental design as a dual modulator of TRPV1 and KDM1A/LSD1, enabling rigorous studies in pain, inflammation, and oncology. This article delivers actionable workflow enhancements, troubleshooting insight, and practical translation of novel findings for maximum experimental impact.

• Magnetic Stimulation Downregulates GABAA ε to Reverse SCZ Be

  2026-06-04

  This study demonstrates that precise magnetic stimulation of the left prelimbic cortex downregulates the GABAA receptor ε subunit, alleviating schizophrenia-like behaviors and synaptic deficits in mice. The findings pinpoint Gabre as a mechanistic target, offering new molecular insights for noninvasive neuromodulation in schizophrenia research.

• Ampicillin Sodium: β-Lactam Antibiotic Workflows & Research

  2026-06-03

  Ampicillin sodium empowers reliable, quantitative antibacterial activity assays and resistance profiling, thanks to its benchmarked β-lactam mechanism. Discover how to optimize protocol execution and troubleshoot common hurdles, leveraging APExBIO's high-purity product for translational and applied research gains.

• Sabutoclax: Mechanistic Breakthroughs for Translational Onco

  2026-06-03

  Explore how Sabutoclax, a potent pan-Bcl-2 inhibitor, reshapes apoptosis induction in cancer research. This article provides mechanistic insights, experimental validation, and strategic guidance for translational scientists aiming to harness multi-targeted apoptosis modulation in robust preclinical workflows.

• Efficient iPSC Differentiation to Retinal Ganglion Cells via

  2026-06-02

  This study establishes a reproducible, chemically defined protocol for differentiating human induced pluripotent stem cells (iPSCs) into retinal ganglion cells (RGCs) with high purity using dual SMAD and Wnt pathway inhibition. The findings offer a robust platform for glaucoma modeling and neurodegeneration research, addressing variability and efficiency challenges in previous protocols.

• JIB-04 Targets Colorectal Cancer Stem Cells via Wnt/β-Cateni

  2026-06-02

  The referenced study identifies JIB-04 as a pan-histone demethylase inhibitor that selectively impairs colorectal cancer stem cell (CSC) self-renewal and tumorigenicity by disrupting Wnt/β-catenin signaling. These findings underscore the therapeutic potential of targeting epigenetic regulators in combating CSC-driven tumor progression and relapse.

• a-MSH, Amide: Mechanistic Insights and Translational Guidanc

  2026-06-01

  This thought-leadership article dissects the mechanistic underpinnings and translational promise of alpha-melanocyte-stimulating hormone amide (a-MSH, amide) in pigmentation and anti-inflammatory research. Integrating recent advances in melanogenesis signaling, evidence from natural product modulators, and strategic recommendations for assay design, it positions APExBIO’s a-MSH, amide as a pivotal tool for researchers addressing pigmentation regulation and hyperpigmentation disorders. The article uniquely bridges molecular insight with actionable strategies, surpassing standard product summaries.

• Minocycline HCl in Retinal Neuroprotection: Protocols & Insi

  2026-06-01

  Minocycline HCl stands apart by bridging antimicrobial, anti-inflammatory, and neuroprotective effects—empowering retina and neurodegeneration models with reproducibility and translational value. Discover protocol-anchored workflows and actionable troubleshooting tips that maximize the potential of APExBIO’s Minocycline HCl for advanced inflammation and cellular signaling studies.

• Phosphotungstic Acid Stains: Illuminating Glycan Targets in

  2026-05-31

  Explore how 2% Phosphotungstic Acid Negative Stain Solution empowers translational researchers to visualize viral glycan vulnerabilities—bridging mechanistic insight from lectin-based studies with advanced electron microscopy protocols. This article delivers practical guidance and strategic vision for next-generation virus imaging and antiviral discovery.

• Phosphotungstic Acid Staining: Unlocking Viral Vulnerabiliti

  2026-05-30

  This thought-leadership article explores how 2% Phosphotungstic Acid Negative Stain Solution revolutionizes electron microscopy for translational researchers targeting viral glycan vulnerabilities. By integrating mechanistic insights from recent lectin-based antiviral studies, the piece delivers strategic guidance for experimental protocol design and future-proofing virus imaging workflows.

• Intestinal TM6SF2 Modulates MASH via Gut–Liver Axis Mechanis

  2026-05-29

  This study reveals that intestinal TM6SF2 plays a pivotal role in protecting against metabolic dysfunction-associated steatohepatitis (MASH) by maintaining gut barrier integrity and modulating the gut microbiota. The findings highlight lysophosphatidic acid signaling as a mechanistic bridge between intestinal lipid handling and hepatic inflammation, informing new research directions and therapeutic approaches.

• MK-0812 and the Gut–Liver Axis: A New Era in Monocyte Traffi

  2026-05-29

  Explore how MK-0812, a potent CCR2 antagonist, is driving innovation in monocyte trafficking and gut–liver axis research. This article uniquely connects advanced MCP-1 signaling inhibition with emerging insights from TM6SF2 and metabolic inflammation studies.

458 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page